Home > Boards > US Listed > Medical - Healthcare > Outlook Therapeutics, Inc. (OTLK)

* * $OTLK Video Chart 09-11-2019 * *

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
ClayTrader Member Profile
Member Level 
Followed By 8,788
Posts 212,870
Boards Moderated 4
Alias Born 12/27/06
160x600 placeholder
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 5/29/2020 7:31:43 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/28/2020 5:06:50 PM
Outlook Therapeutics Announces $16.0 Million Private Placement to Advance the Development of ONS-5010 / LYTENAVA™ (bevacizu... GlobeNewswire Inc. - 5/26/2020 8:05:10 AM
Securities Registration: Employee Benefit Plan (s-8) Edgar (US Regulatory) - 5/15/2020 5:18:25 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/15/2020 5:04:47 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/15/2020 4:54:52 PM
Outlook Therapeutics Reports Financial Results for the Second Quarter of Fiscal Year 2020 and Provides Corporate Update GlobeNewswire Inc. - 5/15/2020 8:00:10 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/11/2020 4:18:25 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/21/2020 6:42:21 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/21/2020 6:41:31 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/21/2020 6:40:21 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/21/2020 6:39:35 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 4/21/2020 6:37:34 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 4/21/2020 6:36:33 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/21/2020 4:19:06 PM
Outlook Therapeutics Bolsters Clinical and Commercial Expertise with Two Key Appointments to Board of Directors GlobeNewswire Inc. - 4/21/2020 8:05:10 AM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 4/20/2020 6:01:08 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/17/2020 5:12:59 PM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 4/17/2020 5:07:43 PM
Outlook Therapeutics to Present at the April 2020 Virtual Investor Summit GlobeNewswire Inc. - 4/15/2020 8:35:10 AM
Outlook Therapeutics Provides COVID-19 Impact Update on Ongoing Clinical Trials NORSE 1 and NORSE 2 GlobeNewswire Inc. - 4/14/2020 8:05:10 AM
Securities Registration Statement (s-1) Edgar (US Regulatory) - 4/8/2020 5:05:13 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/2/2020 5:01:49 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/24/2020 5:23:56 PM
Amended Statement of Beneficial Ownership (sc 13d/a) Edgar (US Regulatory) - 3/24/2020 4:18:43 PM
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist